Volume | 5,388,364 |
|
|||||
News | (2) | ||||||
Day High | 96.94 | Low High |
|||||
Day Low | 94.76 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Abbott Laboratories | ABT | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
96.59 | 94.76 | 96.94 | 95.53 | 96.23 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
69,727 | 5,388,364 | $ 95.78 | $ 516,096,022 | - | 93.25 - 115.83 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:40:26 | 2 | $ 95.54 | USD |
Abbott Laboratories (ABT) Options Flow Summary
Abbott Laboratories Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
165.78B | 1.74B | - | 43.65B | 6.93B | 4.00 | 23.88 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Abbott Laboratories News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 101.16 | 101.35 | 94.76 | 98.21 | 4,065,287 | -5.63 | -5.57% |
1 Month | 104.08 | 105.08 | 94.76 | 100.97 | 4,161,849 | -8.55 | -8.21% |
3 Months | 106.72 | 115.83 | 94.76 | 105.66 | 4,422,194 | -11.19 | -10.49% |
6 Months | 99.13 | 115.83 | 94.76 | 105.78 | 4,743,221 | -3.60 | -3.63% |
1 Year | 100.25 | 115.83 | 93.25 | 104.76 | 5,078,576 | -4.72 | -4.71% |
3 Years | 104.45 | 142.60 | 93.25 | 113.26 | 5,237,245 | -8.92 | -8.54% |
5 Years | 73.02 | 142.60 | 61.61 | 99.99 | 5,583,343 | 22.51 | 30.83% |
Abbott Laboratories Description
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |